In Vitro Testing for Orally Inhaled Products: Developments in Science-Based Regulatory Approaches.
This article is part of a series of reports from the "Orlando Inhalation Conference-Approaches in International Regulation" which was held in March 2014, and coorganized by the University of Florida and the International Pharmaceutical Aerosol Consortium on Regulation and Science (IPAC-RS). The goal of the conference was to foster the exchange of ideas and knowledge across the global scientific and regulatory community in order to identify and help move towards strategies for internationally harmonized, science-based regulatory approaches for the development and marketing approval of inhalation medicines, including innovator and second entry products. This article provides an integrated perspective of case studies and discussion related to in vitro testing of orally inhaled products, including in vitro-in vivo correlations and requirements for in vitro data and statistical analysis that support quality or bioequivalence for regulatory applications.
Institute of Pharmaceutical Science, King's College London, 150 Stamford Street, London, SE1 9NH, UK, Ben.forbes@kcl.ac.uk.
Ben
B
Forbes
Per
P
Bäckman
David
D
Christopher
Myrna
M
Dolovich
Bing V
BV
Li
Beth
B
Morgan
D000280:Administration, Inhalation; D000336:Aerosols; D017277:Drug Approval; D015195:Drug Design; D006801:Humans; D004364:Pharmaceutical Preparations / Q000008:administration & dosage*; D013810:Therapeutic Equivalency
D000336:Aerosols; D004364:Pharmaceutical Preparations